Abstract

Introduction: Successful osseointegration and long term maintenance of endoosseous dental implant are influenced by implant to bone interface requiring continual bone remodeling. Many factors can influence bone remodeling and lead to osseointegration failure. Rheumatoid polyarthritis (RA) is a systemic autoimmune disease characterized by bone damage. Anti-rheumatic drugs such as Methotrexate and Glycocorticoid have deleterious effects on bone metabolism and turnover.

Aim: The aim of this report is to answer to the question whether RA and anti-rheumatic drugs can be a real contraindication for implant treatment.

Observation: A lady was referred for the replacement of the teeth N°14 lost after root fracture. The patient history revealed a Rheumatoid Arthritis diagnosed since 2 years. We decide to suggest her for an implant with immediate provisional crown. The crown was not loaded at the day of surgery. Six months later, the definitive crown was cemented. The implant fulfilled osseointegration clinically and at X-Rays. After 4 years we noticed marginal bone stability.

Conclusion: Although several animal and in vitro studies recorded a negative effect of anti-rheumatic drugs on bone healing many clinical reports showed that patient with RA can be successfully treated with implants but we still need more clinical studies to reinforce our findings.

Keywords: Dental Implants; Rheumatoid Arthritis; Osseointegration; Methotrexate; Glucocorticosteroids

References

1. “Glossary of Periodontal Terms”. 4^th edition. Chicago, IL: The American Academy of Periodontology (2001): 28.
2. Albrektsson T and Wennerberg A. “On osseointegration in relation to implant surfaces”. Clinical Implant Dentistry and Related Research 21 (2019): 4-7.
3. Tavakoli M., et al. “Evaluation of effect of low-dose methotrexate on osseointegration of implants: a biomechanical study on dogs”. The Open Dentistry Journal 12 (2018): 546-554.
4. Haugeberg G. “Focal and generalized bone loss in rheumatoid arthritis: separate or similar concepts”. Nature Clinical Practice Rheumatology 4 (2008): 402-403.
5. Shokri M., et al. “Titanium implant osseointegration in rheumatoid arthritis patients: two case reports”. Journal Dental School 35 (2017): 150-154.
6. Krennmair G., et al. “Dental implants in patients with rheumatoid arthritis: clinical outcome and peri-implant findings”. Journal of Clinical Periodontology 37 (2010): 928-936.
7. Montes CC., et al. “Failing factors associated with osseointegrated dental implant loss”. Implant Dentistry 16 (2007): 404- 412.
8. Petsinis V., et al. “The impact of glucocorticosteroids administered for systemic diseases on the osseointegration and survival of dental implants placed without bone grafting-A retrospective study in 31 patients”. Journal of Cranio-Maxillofacial Surgery 8 (2017): 1197-1200.
9. Annussek T., et al. “Short time administration of antirheumatic drugs-methotrexate as a strong inhibitor of osteoblast’s proliferation In vitro”. Head and Face Medicine 8 (2012): 26.
10. Aghaloo T., et al. “The effects of systemic diseases and medications on implant osseointegration: a systematic review”. The International Journal of Oral and Maxillofacial Implants 34 (2019): s35-s49.

Citation

Citation: Hela Jegham., et al. “Four Year Follow Up of Immediate Provizionalization of Osseointegrated Dental Implant in Patient with Rheumatoid Polyarthritis". Acta Scientific Dental Sciences 4.10 (2020): 53-56.

Copyright

Copyright: © 2020 Hela Jegham., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.